葛兰素史克公司:CEO继任

Translated title of the contribution: GlaxoSmithKline: CEO Succession

Neng Liang (First Author), Yue Yang (Participant Author), Mike Useem (Participant Author)

Research output: Other contributionCase Studies

Abstract

Because the CEO of GlaxoSmithKline, a large pharmaceutical company, would retire after four years, the management board decided to select the appropriate successor among three internal candidates. As the selection of the successor was being reported on by the media, an open “horserace” seemed inevitable. The management board needed to make careful decisions on the selection mechanism, the evaluation methods and, more importantly, the issue of office politics when the three candidates were required to work together during the selection process. Was it possible to find a solution whereby candidates could work together for the purpose of being evaluated, while at the same time the side effects of office politics could be minimized during the open competition? By reading the background materials, students should try to propose solutions to deal with these issues.
Translated title of the contributionGlaxoSmithKline: CEO Succession
Original languageChinese (Simplified)
Number of pages13
Publication statusPublished - 1 Jan 2005

Case number

OB-14-183

Case normative number

OB-14-183-CC

Update date

2016-06-18

Published by

中欧国际工商学院

Keywords

  • 人力资源
  • 制药业
  • 葛兰素史克
  • 领导力
  • 高管继任

Case studies discipline

  • General Management
  • Human Resource Management

Case studies industry

  • Manufacturing

Fingerprint

Dive into the research topics of 'GlaxoSmithKline: CEO Succession'. Together they form a unique fingerprint.

Cite this